Date of publication: April 12, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine Gamaleya. This assessment follows the continue reading : HTAC Recommends Gamaleya COVID-19 Vaccine Sputnik V Under Emergency Use for Reducing COVID-19 Risk in Persons Aged 18 and Older
Evidence brief for 27 March to 08 April 2021
For the period of 27 March to 08 April 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 27 March to 08 April 2021
HTAC Recommends COVID-19 Vaccine Sinovac Under Emergency Use for Reducing COVID-19 Risk in Persons Aged 18 and Older
Date of publication: April 09, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine AstraZeneca. This assessment follows the continue reading : HTAC Recommends COVID-19 Vaccine Sinovac Under Emergency Use for Reducing COVID-19 Risk in Persons Aged 18 and Older
Evidence brief for 20 March to 26 March 2021
For the period of 20 March to 26 March 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 20 March to 26 March 2021